The choice of expression platform is important for the efficient production of the protein for R&D and large-scale production. Different expression systems include bacteria, yeast, insect, and mammalian. Exeris offers research and development services for bio-pharmaceutical companies that develop recombinant proteins as therapeutics. New target-specific protein drugs can be developed by conjugating drugs or toxins to recombinant proteins. We can also chemically modify or process your recombinant proteins for better clinical performance. Computational and Structural Biology expertise combine with scale up and manufacturing know-how to provide cost effective protein production.